131 related articles for article (PubMed ID: 19729946)
41. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
Giuseppe L; Attilio G; Edoardo DN; Loredana G; Cristina L; Vincenzo L
Hematology; 2007 Apr; 12(2):141-7. PubMed ID: 17454195
[TBL] [Abstract][Full Text] [Related]
42. Pituitary abnormalities in Prader-Willi syndrome and early onset morbid obesity.
Miller JL; Goldstone AP; Couch JA; Shuster J; He G; Driscoll DJ; Liu Y; Schmalfuss IM
Am J Med Genet A; 2008 Mar; 146A(5):570-7. PubMed ID: 17431897
[TBL] [Abstract][Full Text] [Related]
43. Use of ovarian reserve parameters for predicting live births in women undergoing in vitro fertilization.
Lukaszuk K; Kunicki M; Liss J; Lukaszuk M; Jakiel G
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):173-7. PubMed ID: 23485092
[TBL] [Abstract][Full Text] [Related]
44. Prenatal determinants of uterine volume and ovarian reserve in adolescence.
Hart R; Sloboda DM; Doherty DA; Norman RJ; Atkinson HC; Newnham JP; Dickinson JE; Hickey M
J Clin Endocrinol Metab; 2009 Dec; 94(12):4931-7. PubMed ID: 19846735
[TBL] [Abstract][Full Text] [Related]
45. Anti-Mullerian hormone as a predictor of follicular reserve in ovarian insufficiency: special emphasis on FSH-resistant ovaries.
Kallio S; Aittomäki K; Piltonen T; Veijola R; Liakka A; Vaskivuo TE; Dunkel L; Tapanainen JS
Hum Reprod; 2012 Mar; 27(3):854-60. PubMed ID: 22258659
[TBL] [Abstract][Full Text] [Related]
46. Sertoli cell markers in the diagnosis of paediatric male hypogonadism.
Grinspon RP; Loreti N; Braslavsky D; Bedecarrás P; Ambao V; Gottlieb S; Bergadá I; Campo SM; Rey RA
J Pediatr Endocrinol Metab; 2012; 25(1-2):3-11. PubMed ID: 22570945
[TBL] [Abstract][Full Text] [Related]
47. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
[TBL] [Abstract][Full Text] [Related]
48. Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?
Muttukrishna S; McGarrigle H; Wakim R; Khadum I; Ranieri DM; Serhal P
BJOG; 2005 Oct; 112(10):1384-90. PubMed ID: 16167941
[TBL] [Abstract][Full Text] [Related]
49. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
[TBL] [Abstract][Full Text] [Related]
50. Serum anti-Müllerian hormone, inhibin B, and total inhibin levels in women with hypothalamic amenorrhea and anorexia nervosa.
Luisi S; Ciani V; Podfigurna-Stopa A; Lazzeri L; De Pascalis F; Meczekalski B; Petraglia F
Gynecol Endocrinol; 2012 Jan; 28(1):34-8. PubMed ID: 21627557
[TBL] [Abstract][Full Text] [Related]
51. Thyroid function from birth to adolescence in Prader-Willi syndrome.
Sharkia M; Michaud S; Berthier MT; Giguère Y; Stewart L; Deladoëy J; Deal C; Van Vliet G; Chanoine JP
J Pediatr; 2013 Sep; 163(3):800-5. PubMed ID: 23623517
[TBL] [Abstract][Full Text] [Related]
52. Body image and sexual interests in adolescents and young adults with Prader-Willi syndrome.
Gross-Tsur V; Eldar-Geva T; Benarroch F; Rubinstein O; Hirsch HJ
J Pediatr Endocrinol Metab; 2011; 24(7-8):469-75. PubMed ID: 21932584
[TBL] [Abstract][Full Text] [Related]
53. The importance of gynecological examination in adolescent girls and adult women with Prader-Willi syndrome.
Srebnik N; Kalifa TM; Hirsch HJ; Benarroch F; Eldar-Geva T; Gross-Tsur V
Am J Med Genet A; 2023 Oct; 191(10):2585-2590. PubMed ID: 37408363
[TBL] [Abstract][Full Text] [Related]
54. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
[TBL] [Abstract][Full Text] [Related]
55. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
56. Anti-Müllerian hormone levels during hormonal contraception in women with polycystic ovary syndrome.
Somunkiran A; Yavuz T; Yucel O; Ozdemir I
Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):196-201. PubMed ID: 17335955
[TBL] [Abstract][Full Text] [Related]
57. Gonadal Hormone Substitution in People with Prader-Labhart-Willi Syndrome: An International Prader-Willi Syndrome Organisation Survey.
Eiholzer U; Stephan A; Fritz C; Katschnig C; Noordam C;
Horm Res Paediatr; 2021; 94(5-6):176-185. PubMed ID: 34348303
[TBL] [Abstract][Full Text] [Related]
58. Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.
Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
Growth Horm IGF Res; 2010 Jun; 20(3):179-84. PubMed ID: 20199883
[TBL] [Abstract][Full Text] [Related]
59. Ovarian follicular development and the follicular fluid hormones and growth factors in normal women of advanced reproductive age.
Klein NA; Battaglia DE; Miller PB; Branigan EF; Giudice LC; Soules MR
J Clin Endocrinol Metab; 1996 May; 81(5):1946-51. PubMed ID: 8626862
[TBL] [Abstract][Full Text] [Related]
60. Anti-Mullerian Hormone (AMH) levels in serum and follicular fluid as predictors of ovarian response in stimulated (IVF and ICSI) cycles.
Tolikas A; Tsakos E; Gerou S; Prapas Y; Loufopoulos A
Hum Fertil (Camb); 2011 Dec; 14(4):246-53. PubMed ID: 22088130
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
